Thyroid Cancer, Iodine Nutrition, and Autoimmune Thyroid Disease
This community focuses on the clinical management of thyroid malignancies, the assessment of iodine intake and deficiency, and the treatment of autoimmune conditions like Graves' disease and Hashimoto’s thyroiditis.
The research centers on differentiated thyroid carcinoma, particularly papillary thyroid cancer, and the efficacy of radioactive iodine therapy. A significant portion of the work examines iodine status, including the impact of iodized salt and iodine deficiency on thyroid function. Clinical management of hyperthyroidism and hypothyroidism is also prominent, with specific attention to thyroid function in pregnant women and children. The literature frequently addresses lymph node metastasis, thyroid nodules, and the long-term monitoring of patients undergoing radioiodine treatment.
Iodine accounts for the largest share of this community's output, representing 13.6% of all iodine research, and 21,450 papers here. Technetium is the second-largest share at 3.9% of its element research, with 719 papers. Sodium and potassium each contribute 0.7% of their respective element research, with 2,253 and 1,397 papers in this community.
The community comprises 35,596 papers, primarily published in Thyroid, The Journal of Clinical Endocrinology & Metabolism, and Endocrinology.
Recent work includes guidelines for thyroid disease in pregnancy, the role of gut microbiota in hypothyroidism, and the impact of environmental pollutants on thyroid function.